Entecavir maleate versus Entecavir in Chinese patients with HBeAg-Positive Chronic Hepatitis B: Results at 48 and 96 weeks of a Randomized Double-blind Multicenter Clinical Trial

被引：0
|
作者：
Yu, Yanyan [1 ]
Xu, Jinghang [1 ]
Tang, Hong [2 ]
Zhang, Dazhi [3 ]
Mao, Qing [4 ]
Li, Jun [5 ]
Xu, Zhongnan [6 ]
Zhang, Xiquan [6 ]
Dai, Jun [6 ]
Si, Chongwen [1 ]
机构：
[1] Peking Univ, Dept Infect Dis, Hosp 1, Beijing 100871, Peoples R China
[2] Sichuan Univ, Dept Infect Dis, W China Hosp, Chengdu 610064, Peoples R China
[3] Chongqing Med Univ, Dept Infect Dis, Affiliated Hosp 2, Chongqing, Peoples R China
[4] Third Mililary Med Univ, Dept Infect Dis, Affiliated Hosp 1, Chongqing, Peoples R China
[5] Nanjing Med Univ, Dept Infect Dis, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China
[6] Jiangsu Chia Tai Tianqing Pharmaceut Co Ltd, Nanjing, Jiangsu, Peoples R China
来源：
HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
417
引用
收藏
页码：397A / 398A
页数：2
相关论文
共 50 条
  • [41] Editorial: identifying candidates for pegylated interferon add-on to entecavir therapy in patients with HBeAg-positive chronic hepatitis B
    Peng, Cheng-Yuan
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (05) : 609 - 610
  • [42] Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial
    Hou, Jinlin
    Yin, You-Kuan
    Xu, Daozhen
    Tan, Deming
    Niu, Junqi
    Zhou, Xiaqiu
    Wang, Yuming
    Zhu, Limin
    He, Yongwen
    Ren, Hong
    Wan, Mobin
    Chen, Chengwei
    Wu, Shanming
    Chen, Yagang
    Xu, Jiazhang
    Wang, Qinhuan
    Wei, Lai
    Chao, George
    Constance, Barbara Fielman
    Harb, George
    Brown, Nathaniel A.
    Jia, Jidong
    HEPATOLOGY, 2008, 47 (02) : 447 - 454
  • [43] Adefovir Dipivoxil plus Chinese Medicine in HBeAg-Positive Chronic Hepatitis B Patients: A Randomized Controlled 48-Week Trial
    Li Xiao-ke
    Zhang Ming-xiang
    Shao Feng-zhen
    Zhou De-wen
    Xue Jing-dong
    Liu Tie-jun
    Chi Xiao-ling
    Lu Bing-jiu
    Wang Xian-bo
    Li Qin
    Li Jun
    Mao De-wen
    Yang Hua-sheng
    Yang Hong-zhi
    Zhao Wen-xia
    Li Yong
    Zhang Guo-liang
    Zhao Yi-ming
    Zou Jian-dong
    Liu Meng-yang
    Zhang Ke-ke
    Yang Xian-zhao
    Gan Da-nan
    Li Ying
    Zhang Peng
    Li Zhi-guo
    Li Shuo
    Ye Yong-an
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2020, 26 (05) : 330 - 338
  • [44] Efficacy and safety of entecavir compared to lamivudine in nucleoside-naive patients with chronic hepatitis B: a randomized double-blind trial in China
    Yao, Guangbi
    Chen, Chengwei
    Lu, Weilun
    Ren, Hong
    Tan, Deming
    Wang, Yuming
    Xu, Daozheng
    Jiang, Zhengrong
    Liu, Jessica
    Xu, Dong
    MacDonald, Laurie
    HEPATOLOGY INTERNATIONAL, 2007, 1 (03) : 365 - 372
  • [45] COST-EFFECTIVENESS OF PEGINTERFERON ALFA-2A VERSUS ENTECAVIR IN THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA
    Sheng, F.
    VALUE IN HEALTH, 2009, 12 (07) : A428 - A429
  • [46] Telbivudine Versus Entecavir for Nucleos(t)ide-Naive HBeAg-Positive Chronic Hepatitis B: A Meta-analysis
    Liu, Hmin
    Wang, Xbo
    Wan, Gang
    Yang, Zyun
    Zeng, Hui
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2014, 347 (02): : 131 - 138
  • [47] Adefovir Dipivoxil plus Chinese Medicine in HBeAg-Positive Chronic Hepatitis B Patients: A Randomized Controlled 48-Week Trial
    LI Xiao-ke
    ZHANG Ming-xiang
    SHAO Feng-zhen
    ZHOU Da-qiao
    XUE Jing-dong
    LIU Tie-jun
    CHI Xiao-ling
    LU Bing-jiu
    WANG Xian-bo
    LI Qin
    LI Jun
    MAO De-wen
    YANG Hua-sheng
    YANG Hong-zhi
    ZHAO Wen-xia
    LI Yong
    ZHANG Guo-liang
    ZHAO Yi-ming
    ZOU Jian-dong
    LIU Meng-yang
    ZHANG Ke-ke
    YANG Xian-zhao
    GAN Da-nan
    LI Ying
    ZHANG Peng
    LI Zhi-guo
    LI Shuo
    YE Yong-an
    Chinese Journal of Integrative Medicine, 2020, (05) : 330 - 338
  • [48] Adefovir Dipivoxil plus Chinese Medicine in HBeAg-Positive Chronic Hepatitis B Patients: A Randomized Controlled 48-Week Trial
    Xiao-ke Li
    Ming-xiang Zhang
    Feng-zhen Shao
    Da-qiao Zhou
    Jing-dong Xue
    Tie-jun Liu
    Xiao-ling Chi
    Bing-jiu Lu
    Xian-bo Wang
    Qin Li
    Jun Li
    De-wen Mao
    Hua-sheng Yang
    Hong-zhi Yang
    Wen-xia Zhao
    Yong Li
    Guo-liang Zhang
    Yi-ming Zhao
    Jian-dong Zou
    Meng-yang Liu
    Ke-ke Zhang
    Xian-zhao Yang
    Da-nan Gan
    Ying Li
    Peng Zhang
    Zhi-guo Li
    Shuo Li
    Yong-an Ye
    Chinese Journal of Integrative Medicine, 2020, 26 : 330 - 338
  • [49] Adefovir Dipivoxil plus Chinese Medicine in HBeAg-Positive Chronic Hepatitis B Patients: A Randomized Controlled 48-Week Trial
    LI Xiaoke
    ZHANG Mingxiang
    SHAO Fengzhen
    ZHOU Daqiao
    XUE Jingdong
    LIU Tiejun
    CHI Xiaoling
    LU Bingjiu
    WANG Xianbo
    LI Qin
    LI Jun
    MAO Dewen
    YANG Huasheng
    YANG Hongzhi
    ZHAO Wenxia
    LI Yong
    ZHANG Guoliang
    ZHAO Yiming
    ZOU Jiandong
    LIU Mengyang
    ZHANG Keke
    YANG Xianzhao
    GAN Danan
    LI Ying
    ZHANG Peng
    LI Zhiguo
    LI Shuo
    YE Yongan
    Chinese Journal of Integrative Medicine, 2020, 26 (05) : 330 - 338
  • [50] Bushenjianpi formula combined with entecavir for HBeAg-negative chronic hepatitis B patients: a multicentre, randomised, double-blind, placebo-controlled trial
    Gao, Yue-Qiu
    Zhang, Xin
    Li, Man
    Zhou, Zhen-Hua
    Sun, Xue-Hua
    Zhu, Xiao-Jun
    Jin, Shu-Gen
    LANCET, 2016, 388 : 33 - 33
12345